ArticleProtein science : a publication of the Protein Society2026
Differences in Src phosphorylation of PSD-93 and PSD-95 drive differences in scaffolding activity.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Differences in Src phosphorylation of PSD-93 and PSD-95 drive differences in scaffolding activity.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Scaffold proteins contain multiple binding modules that allow for co-localization of proteins that lack a direct interaction. Evolution resulted in different combinations of binding modules that rewired existing signal transduction pathways. The synaptic Membrane-Associated Guanylate Kinase (MAGuK) scaffold proteins post-synaptic density protein 93 (PSD-93) and post-synaptic density protein 95 (PSD-95) share the same organization of highly conserved binding domains connected by divergent linkers, which generates opposing functions in synaptic plasticity. Both are targets for tyrosine phosphorylation by Src kinase, but the extent and impacts of phosphorylation are poorly understood. Here, we characterized the in vitro phosphorylation of PSD-93 and PSD-95. Both were targeted at multiple sites that were similarly distributed, but PSD-93 was a more robust substrate. While Src kinase has been linked to synaptic plasticity, the direct effects on MAGuK function are not known. We found that phosphorylation differentially affected the affinity of PSD-93 and PSD-95 for postsynaptic client proteins. Phosphorylation also elicited opposite responses in recruitment of key synaptic clients by MAGuKs into supercomplexes, which we equate with scaffolding activity. Surprisingly, phosphorylation affected biomolecular condensation in PSD-93 but not PSD-95, which suggests that the affinity of protein interactions is disconnected from phase separation. Phosphorylation had minimal impacts on the supertertiary structure as assessed by small angle x-ray scattering although single molecule fluorescence resonance energy transfer revealed altered dynamics leaving the origin of functional effects unclear. PSD-95 appears optimized to work with small protein numbers while PSD-93 modulates condensation at higher protein concentrations. This difference suggests action at different stages of synapse maturation, which could be linked to synaptic plasticity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.